1660 related articles for article (PubMed ID: 16638033)
21. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
22. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
[TBL] [Abstract][Full Text] [Related]
24. Analysis of risk factors for persistent gestational trophoblastic disease.
Khoo SK; Baartz D; Sidhu M; Yip WL; Tripcony L
Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):657-9. PubMed ID: 20070718
[TBL] [Abstract][Full Text] [Related]
25. Repetitive complete and partial hydatidiform mole.
Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
[TBL] [Abstract][Full Text] [Related]
26. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic disease.
Garner EI; Goldstein DP; Feltmate CM; Berkowitz RS
Clin Obstet Gynecol; 2007 Mar; 50(1):112-22. PubMed ID: 17304028
[TBL] [Abstract][Full Text] [Related]
30. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Gillespie AM; Kumar S; Hancock BW
Br J Cancer; 2000 Apr; 82(8):1393-5. PubMed ID: 10780516
[TBL] [Abstract][Full Text] [Related]
31. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
33. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
34. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
Lertkhachonsuk R; Limpongsanurak S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
[TBL] [Abstract][Full Text] [Related]
35. Natural history of partial molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
[TBL] [Abstract][Full Text] [Related]
36. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
37. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
38. Development of postmolar trophoblastic disease after partial molar pregnancy.
Goto S; Yamada A; Ishizuka T; Tomoda Y
Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686
[TBL] [Abstract][Full Text] [Related]
39. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
40. Current management of complete and partial molar pregnancy.
Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):139-46. PubMed ID: 8035368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
